IL17A and acute myeloid leukemia: For example, the application of CD33-CAR-NK92 cells in patients with relapsed or refractory acute myeloid leukemia (AML) resulted in fever (reaching up to 40°C) and grade I CRS, accompanied by increased serum levels of IL-10 and IL-17.